Published in Ann N Y Acad Sci on March 30, 1978
Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study. PLoS One (2013) 1.47
Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer (2008) 1.26
The impact of preventive cardiology on coronary artery disease. CMAJ (1988) 1.01
Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey. BMJ Open (2015) 0.75
Performance of a five-item mental health screening test. Med Care (1991) 8.76
Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med (1977) 8.60
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 8.52
Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal (1995) 7.45
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 6.80
Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health (1987) 6.21
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA (1997) 5.36
The cost of a successful delivery with in vitro fertilization. N Engl J Med (1994) 4.94
Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatry (1987) 4.62
Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making (1985) 4.47
Gains in life expectancy from medical interventions--standardizing data on outcomes. N Engl J Med (1998) 4.47
Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol (1987) 3.77
Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation (1991) 3.75
Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health (1985) 3.31
Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med (1993) 3.27
Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med (1993) 2.85
Use and misuse of the term "cost effective" in medicine. N Engl J Med (1986) 2.82
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med (2000) 2.71
The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA (1998) 2.69
Toward developing a relative value scale for medical and surgical services. Health Care Financ Rev (1979) 2.67
Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension. N Engl J Med (1977) 2.54
When doctors meet numbers. Am J Med (1981) 2.48
A cost-effectiveness analysis of exercise as a health promotion activity. Am J Public Health (1988) 2.46
Do medical devices have enhanced placebo effects? J Clin Epidemiol (2000) 2.45
Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care (2000) 2.41
Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol (2001) 2.37
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA (1999) 2.35
Who gets chemotherapy for metastatic lung cancer? Chest (2000) 2.27
Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med (1991) 2.25
Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22
Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med (2000) 2.21
Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol (1993) 2.18
Preference-based measures in economic evaluation in health care. Annu Rev Public Health (2000) 2.18
The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil (2005) 2.11
On the decision rules of cost-effectiveness analysis. J Health Econ (1993) 2.09
The cost-effectiveness of air bags by seating position. JAMA (1997) 2.09
Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA (1990) 2.01
Cost and health implications of cholesterol lowering. Circulation (1992) 2.00
Preferences for health outcomes. Comparison of assessment methods. Med Decis Making (1984) 1.97
What do patients value? Willingness to pay for ultrasound in normal pregnancy. Med Care (1985) 1.96
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med (1992) 1.92
Elective hysterectomy. Benefits, risks, and costs. Med Care (1985) 1.87
Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199. J Vasc Interv Radiol (1993) 1.87
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology (1999) 1.87
Pertussis vaccine--an analysis of benefits, risks and costs. N Engl J Med (1979) 1.75
Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol (1986) 1.75
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol (2001) 1.72
Cardiac surgery in bacterial endocarditis. Circulation (1968) 1.70
Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. S Afr Med J (2006) 1.67
Cost-effectiveness of regulations against using a cellular telephone while driving. Med Decis Making (1999) 1.58
Cost-effectiveness of routine coronary angiography after acute myocardial infarction. Circulation (1996) 1.58
Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics (1997) 1.56
Learning by doing in CABG surgery. Med Care (1990) 1.56
Cost-effectiveness of a new short-stay unit to "rule out" acute myocardial infarction in low risk patients. J Am Coll Cardiol (1994) 1.55
The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy. AIDS (2000) 1.51
Physiologic and clincical observations on furosemide and ethacrynic acid. Ann N Y Acad Sci (1966) 1.50
Managing quality in hospital practice. Int J Qual Health Care (1998) 1.44
Cost-effectiveness study of the extracorporeal shock-wave lithotriptor. Int J Technol Assess Health Care (1990) 1.43
Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA (1991) 1.42
Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA (2000) 1.42
Furosemide. A clinical evaluation of its diuretic action. Circulation (1966) 1.40
Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method. Med Decis Making (1998) 1.39
Allocation of subjects in medical experiments. 1974. MD Comput (1995) 1.38
Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers. Med Care (1999) 1.37
Allocation of subjects in medical experiments. N Engl J Med (1974) 1.35
Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med (1988) 1.33
Estrogen use in postmenopausal women--costs, risks, and benefits. N Engl J Med (1980) 1.31
Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med (1986) 1.29
Challenges for cost-effectiveness research. Med Decis Making (1986) 1.25
Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang (2004) 1.22
Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med (1996) 1.22
Cost-effectiveness of hormone replacement therapy in the menopause. Obstet Gynecol Surv (1983) 1.22
The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med (1999) 1.22
Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Making (2000) 1.20
A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterol Motil (2007) 1.20
Evaluating the cost-effectiveness of clinical and public health measures. Annu Rev Public Health (1998) 1.20
Economic assessments of medical practices and technologies. Med Decis Making (1981) 1.19
Factors contributing to practice variation in post-stroke rehabilitation. Health Serv Res (1997) 1.17
Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med (1990) 1.16
Are healthy-years equivalents an improvement over quality-adjusted life years? Med Decis Making (1994) 1.13
Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol (1997) 1.10
Oregon's Medicaid ranking and cost-effectiveness: is there any relationship? Med Decis Making (1996) 1.08
Determinants of dropout rate among hypertensive patients in an urban clinic. J Community Health (1979) 1.08
Coronary artery bypass graft surgery: clinical decision making and cost-effectiveness analysis. Med Decis Making (1981) 1.06
Cost-effectiveness of coronary artery bypass surgery. Circulation (1982) 1.04
Using health-related quality-of-life information: clinical encounters, clinical trials, and health policy. J Gen Intern Med (1994) 1.04
Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model. Circulation (1989) 1.04
Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care (2001) 1.04
A QALY is a QALY--or is it? J Health Econ (1988) 1.03
Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis. Clin Infect Dis (2002) 1.03
Impact of patient perceptions on compliance with treatment for hypertension. Med Care (1978) 1.03
Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence. Am J Public Health (1991) 1.02
Cost-effective priorities for cancer prevention. Science (1983) 1.02